Otmane El Rhazi from Investor's Business Daily - Investing RSS.
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina (ILMN), Celgene (CELG) and Regeneron Pharmaceuticals continue to trade well post-breakout. Technology names haven't disappointed either. LinkedIn (LNKD) looks solid after reporting strong earnings last
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina (ILMN), Celgene (CELG) and Regeneron Pharmaceuticals continue to trade well post-breakout. Technology names haven't disappointed either. LinkedIn (LNKD) looks solid after reporting strong earnings last
No comments:
Post a Comment